GlassScriptPhysician profile
Robert J Carpenter
NPI 1306824123
$3,778.89
in general payments reported to CMS, 2019-2025
12 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,226 · 2020: $193 · 2021: $299 · 2022: $279 · 2023: $357 · 2024: $265 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,054.00 | 2019 | |
| Endo Pharmaceuticals INC. | $817.73 | 2019-2024 | Xiaflex |
| Mentor Worldwide LLC | $258.89 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Endo USA, INC. | $238.36 | 2024-2025 | Xiaflex |
| Merz North America, INC. | $199.75 | 2019-2023 | Xeomin |
| Acelrx Pharmaceuticals, INC. | $80.78 | 2020-2022 | |
| Tela Bio, INC. | $27.68 | 2024 | Ovitex 2s |
| Stryker Corporation | $27.50 | 2025 | Variax |
| Organogenesis INC. | $23.47 | 2023 | Puraply |
| Genentech USA, INC. | $19.67 | 2020 | |
| Galderma Laboratories, L.P. | $17.63 | 2021 | |
| Tactile Systems Technology INC | $13.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.